ASSOCIATION BETWEEN THE AGE OF PREGNANT WOMEN AND PARITY WITH THE INCIDENCE OF PLACENTA PREVIA : SYSTEMATIC REVIEW

Prayudha Tegar Perbawa; Mutia Juliana

doi:10.53555/nnmhs.v9i3.1621

Authors

Prayudha Tegar Perbawa Faculty of Medicine, General Achmad Yani University, Indonesia Author
Mutia Juliana Faculty of Midwifery, Immanuel School of Health Sciences, Indonesia Author

DOI:

https://doi.org/10.53555/nnmhs.v9i3.1621

Keywords:

Age, Parity, Placenta Previa, Pregnancy

Abstract

Placenta previa is associated with an increased risk of premature birth, fetal death during intrauterine development, and asphyxia in neonates. Vaginal bleeding that is not unpleasant is one of the telltale signs of placenta previa. It is estimated that 5.2% of pregnancies would be affected by the common obstetric condition known as placenta previa. Sometimes there are no symptoms associated with placenta previa. During the second half of pregnancy, the primary symptom is vaginal bleeding that is brilliant red and completely painless. Moreover, this syndrome can cause excessive bleeding prior to or throughout the labor process. The uterus should have some scars on it as a result of a surgery or procedure that was performed in the past. a previous pregnancy in which you experienced placenta previa is considered to be a risk factor. Having a previous cesarean section (CS), having an abortion, being older than 35 years old, having more than one child, and using assisted reproductive technologies (ART) such in vitro fertilization are all variables that can increase the likelihood of developing placenta previa (IVF). It appears that the risk of placenta previa increases with both the mother's age and the number of previous pregnancies. Despite the fact that research has shown that the association is not consistent at all.

References

Cresswell JA, Ronsmans C, Calvert C, Filippi V. Prevalence of placenta praevia by world region: a systematic review and meta‐analysis. Trop Med Int Heal. 2013;18(6):712–24.

Faiz AS, Ananth C V. Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. J Matern neonatal Med. 2003;13(3):175–90.

Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005 May;192(5):1458–61.

Matsuzaki S, Mandelbaum RS, Sangara RN, McCarthy LE, Vestal NL, Klar M, et al. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States. Am J Obstet Gynecol. 2021 Nov;225(5) :534.e1-534.e38.

Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018 Jan;218(1):75–87.

Karami M, Jenabi E, Fereidooni B. The association of placenta previa and assisted reproductive techniques: a metaanalysis. J Matern Neonatal Med. 2018;31(14):1940–7.

Committee opinion no. 529: placenta accreta. Obstet Gynecol. 2012 Jul;120(1):207–11.

Gibbins KJ, Einerson BD, Varner MW, Silver RM. Placenta previa and maternal hemorrhagic morbidity. J Matern neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2018 Feb;31(4):494– 9.

Gao Y, Gao X, Cai J, Han F, Xu G, Zhang X, et al. Prediction of placenta accreta spectrum by a scoring system based on maternal characteristics combined with ultrasonographic features. Taiwan J Obstet Gynecol. 2021 Nov;60(6):1011–7.

King LJ, Mackeen AD, Nordberg C, Paglia MJ. Maternal risk factors associated with persistent placenta previa. Placenta. 2020;99:189–92.

Ozdemirci S, Akpinar F, Baser E, Bilge M, Unlubilgin E, Yucel A, et al. Effect of the delivery way and number of parity in the subsequent incidence of placenta previa. J Matern neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2020 Oct;33(19):3238–43.

Kuribayashi M, Tsuda H, Ito Y, Tezuka A, Ando T, Tamakoshi K, et al. Evaluation of the risk factors for antepartum hemorrhage in cases of placenta previa: a retrospective cohort study. J Int Med Res. 2021 Nov;49(11):3000605 211054706.

Heena AB, Kumari G. Retrospective study of placenta accreta, placenta increta and placenta percreta in Peripartum hysterectomy specimens. Indian J Pathol Microbiol. 2020 Feb;63(Supplement):S87–90.

Romeo V, Verde F, Sarno L, Migliorini S, Petretta M, Mainenti PP, et al. Prediction of placenta accreta spectrum in patients with placenta previa using clinical risk factors, ultrasound and magnetic resonance imaging findings. Radiol Med. 2021;126(9):1216–25.

Martimucci K, Bilinski R, Perez AM, Kuhn T, Al-Khan A, Alvarez-Perez JR. Interpregnancy interval and abnormally invasive placentation. Acta Obstet Gynecol Scand. 2019 Feb;98(2):183–7.

Cunningham FG; et al, Cunningham FG; Leveno KJ; Bloom SL; et al, F. Gary Cunningham, Kenneth J. Leveno, Steven L. Bloom, Catherine Y. Spong, Jodi S. Dashe BLH. Williams Obstetri. 25th ed. New York: The McGrawHill Companies; 2020.

Frah AMA. The Association of Placenta Previa withCesarean Delivery Using Ultrasound. Sudan University of Science and Technology; 2016.

Rac MWF, Dashe JS, Wells CE, Moschos E, McIntire DD, Twickler DM. Ultrasound predictors of placental invasion: the Placenta Accreta Index. Am J Obstet Gynecol. 2015 Mar;212(3):343.e1-7.

Iacovelli A, Liberati M, Khalil A, Timor-Trisch I, Leombroni M, Buca D, et al. Risk factors for abnormally invasive placenta: a systematic review and meta-analysis. J Matern neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2020 Feb;33(3):471–81.

Cochrane E, Pando C, Kirschen GW, Soucier D, Fuchs A, Garry DJ. Assisted reproductive technologies (ART) and placental abnormalities. J Perinat Med. 2020 Oct;48(8):825–8.

Dai J, Shi Y, Wu Y, Guo L, Lu D, Chen Y, et al. The interaction between age and parity on adverse pregnancy and neonatal outcomes. Front Med. 2023;10:1056064.